Apex Healthcare Berhad (KLSE:AHEALTH)
Malaysia
· Delayed Price · Currency is MYR 2.120
0.00 (0.00%)
At close: Mar 28, 2025
Apex Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 961.78 | 936.17 | 877.74 | 770.76 | 698.73 | Upgrade
|
| Revenue Growth (YoY) | 2.74% | 6.66% | 13.88% | 10.31% | 1.44% | Upgrade
|
| Cost of Revenue | 736.18 | 721.34 | 680.15 | 609.78 | 550.51 | Upgrade
|
| Gross Profit | 225.59 | 214.83 | 197.59 | 160.97 | 148.22 | Upgrade
|
| Selling, General & Admin | 128.26 | 123.86 | 112 | 98.08 | 93.29 | Upgrade
|
| Other Operating Expenses | -6.78 | 12.2 | -2.14 | -2.77 | -4.75 | Upgrade
|
| Operating Expenses | 121.47 | 136.06 | 109.87 | 95.31 | 88.54 | Upgrade
|
| Operating Income | 104.12 | 78.77 | 87.73 | 65.66 | 59.67 | Upgrade
|
| Interest Expense | -1.4 | -0.56 | -0.76 | -0.86 | -1.15 | Upgrade
|
| Interest & Investment Income | 7.81 | 6.86 | 1.62 | 1.82 | 1.79 | Upgrade
|
| Earnings From Equity Investments | -9.78 | 336.4 | 29.57 | 7.1 | 8.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.25 | 1.55 | 1.51 | 1.25 | 0.99 | Upgrade
|
| EBT Excluding Unusual Items | 100.99 | 423.02 | 119.66 | 74.96 | 69.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.2 | 0.28 | 0.69 | 0.18 | 0.18 | Upgrade
|
| Pretax Income | 101.2 | 423.31 | 120.36 | 75.41 | 70.17 | Upgrade
|
| Income Tax Expense | 24.66 | 25.32 | 19.38 | 15.98 | 14.16 | Upgrade
|
| Earnings From Continuing Operations | 76.54 | 397.99 | 100.97 | 59.44 | 56.01 | Upgrade
|
| Minority Interest in Earnings | - | - | 0 | -0.02 | 0.01 | Upgrade
|
| Net Income | 76.54 | 397.99 | 100.97 | 59.42 | 56.02 | Upgrade
|
| Net Income to Common | 76.54 | 397.99 | 100.97 | 59.42 | 56.02 | Upgrade
|
| Net Income Growth | -80.77% | 294.15% | 69.94% | 6.06% | 6.20% | Upgrade
|
| Shares Outstanding (Basic) | 715 | 714 | 711 | 710 | 710 | Upgrade
|
| Shares Outstanding (Diluted) | 715 | 715 | 714 | 711 | 712 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.16% | 0.33% | -0.14% | 0.34% | Upgrade
|
| EPS (Basic) | 0.11 | 0.56 | 0.14 | 0.08 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.56 | 0.14 | 0.08 | 0.08 | Upgrade
|
| EPS Growth | -80.78% | 293.50% | 69.46% | 6.10% | 5.92% | Upgrade
|
| Free Cash Flow | 41.03 | 39.26 | 41.76 | 50.85 | 69.66 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.06 | 0.06 | 0.07 | 0.10 | Upgrade
|
| Dividend Per Share | 0.090 | 0.050 | 0.043 | 0.037 | 0.030 | Upgrade
|
| Dividend Growth | 80.00% | 15.47% | 17.98% | 22.33% | 21.46% | Upgrade
|
| Gross Margin | 23.46% | 22.95% | 22.51% | 20.89% | 21.21% | Upgrade
|
| Operating Margin | 10.83% | 8.41% | 9.99% | 8.52% | 8.54% | Upgrade
|
| Profit Margin | 7.96% | 42.51% | 11.50% | 7.71% | 8.02% | Upgrade
|
| Free Cash Flow Margin | 4.27% | 4.19% | 4.76% | 6.60% | 9.97% | Upgrade
|
| EBITDA | 123.09 | 95.47 | 103.03 | 80.8 | 74.88 | Upgrade
|
| EBITDA Margin | 12.80% | 10.20% | 11.74% | 10.48% | 10.72% | Upgrade
|
| D&A For EBITDA | 18.97 | 16.69 | 15.31 | 15.14 | 15.21 | Upgrade
|
| EBIT | 104.12 | 78.77 | 87.73 | 65.66 | 59.67 | Upgrade
|
| EBIT Margin | 10.83% | 8.41% | 9.99% | 8.52% | 8.54% | Upgrade
|
| Effective Tax Rate | 24.36% | 5.98% | 16.11% | 21.18% | 20.18% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.